Top Markets
#1 Geodnet Geodnet +29.44%
#2 XPIN Network XPIN Network +28.39%
#3 Ore Ore +23.60%
#4 EXOD EXOD +22.08%
#5 AUKI AUKI +21.42%
#6 The Black Bull The Black Bull +21.41%
#7 Verus Coin Verus Coin +20.47%
#8 Arowana Arowana +20.04%
#9 SSV Network SSV Network +17.92%
#10 Ethena Staked ENA Ethena Staked ENA +16.65%
Coin of the day
Geodnet Geodnet
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Sirnaomics Ltd. Sirnaomics Ltd.

Sirnaomics Ltd.

2257
Classifica tra le azioni #25060
Sirnaomics Ltd. is an RNA therapeutics biopharmaceutical company, founded in... Sirnaomics Ltd. is an RNA therapeutics biopharmaceutical company, founded in 2007 and headquartered in Gaithersburg, Maryland. The company is dedicated to identifying and developing innovative therapeutic compounds aimed at addressing significant medical needs across the United States and the People's Republic of China. Its leading pipeline assets include STP705, which is being investigated for conditions such as cutaneous squamous cell carcinoma in situ, basal cell carcinoma, various liver-related cancers (cholangiocarcinoma, hepatocellular carcinoma, liver metastases), as well as for keloid scar remodeling, hypertrophic scarring, and fat sculpting. Another prominent candidate, STP707, is designed to treat cholangiocarcinoma, hepatocellular carcinoma, liver metastases, metastatic cutaneous squamous cell carcinoma, non-small cell lung cancer, and both liver and lung fibrosis. Beyond these lead programs, Sirnaomics is advancing STP355 for a range of cancers; STP369 for head and neck/bladder cancers; STP779 for liver, lung, and pancreatic cancers; and STP902 for breast cancer. The company's portfolio also extends to infectious diseases with STP702 for influenza, STP908 for COVID-19, the RIM730 COVID-19 vaccine, and STP909 for HPV/cervical cancer. Furthermore, its developmental pipeline encompasses STP122G for thrombotic disorders, STP125G for hypertriglyceridemia, STP144G for complement-mediated ailments, STP133G for cardiometabolic conditions, and STP155G for hepatitis B virus.
Prezzo delle azioni
$0.49443488
Capitalizzazione di mercato
$53.84M
Variazione (1 giorno)
-0.90%
Variazione (1 anno)
-60.89%
Paese
US
Scambia Sirnaomics Ltd. (2257)

Categoria

Healthcare
Storico del prezzo dell'azione per Sirnaomics Ltd. (2257)
Prezzo di chiusura più alto: $0.52 il 2026-08-01

Prezzo di chiusura più basso: $10.80 il 2021-12-01
Storico del prezzo dell'azione di Sirnaomics Ltd. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 2.53%
2025 149.70%
2024 -92.27%
2023 -25.74%
2022 -34.59%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $760.57 8.46%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US